Immunoglobulin allotypic markers in Kawasaki disease.

[1]  W. Klitz,et al.  The HLA class II region and susceptibility to Kawasaki disease. , 1992, Tissue antigens.

[2]  S. Shulman,et al.  Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. , 1987, American journal of diseases of children.

[3]  Rauch Am.  Kawasaki syndrome: critical review of U.S. epidemiology. , 1987, Progress in clinical and biological research.

[4]  T. Sasazuki,et al.  Genetic analysis of Kawasaki syndrome. , 1986, American journal of human genetics.

[5]  R. Kaslow,et al.  Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination. , 1985, Arthritis and rheumatism.

[6]  A. Krensky,et al.  Epedimic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome , 1983 .

[7]  Y. Danon,et al.  HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients. , 2008, Tissue antigens.

[8]  A. Dean,et al.  An epidemic of Kawasaki syndrome in Hawaii† , 1982, The Journal of Pediatrics.

[9]  A. Krensky,et al.  HLA antigens in mucocutaneous lymph node syndrome in New England. , 1981, Pediatrics.

[10]  M. Melish.  Kawasaki syndrome: a new infectious disease? , 1981, The Journal of infectious diseases.

[11]  A. Steinberg,et al.  The distribution of the human immunoglobulin allotypes , 1981 .

[12]  T. Kawasaki,et al.  HLA antigens in Kawasaki disease. , 1978, Pediatrics.

[13]  I. Matsuda,et al.  HLA antigens in mucocutaneous lymph node syndrome. , 1977, American journal of diseases of children.

[14]  Daniel P. Stites,et al.  Basic and Clinical Immunology , 1976 .

[15]  L. Rivat,et al.  [Genetic markers of human immunoglobulins]. , 1968, L' Annee biologique.